{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:19:32Z","timestamp":1790399972558,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BAAINBwU","award":["E\/U2ED\/PD015\/OF551"],"award-info":[{"award-number":["E\/U2ED\/PD015\/OF551"]}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The highly potent opioid carfentanil (CAR) represents a growing health risk. CAR acts via G<jats:sub>i\/o<\/jats:sub>-coupled \u00b5 opioid receptors (\u00b5OR) and exhibits ultra-high toxicity. So far, no clear association between pharmacodynamics and toxicity of CAR has been described. We created a HEK-293 cell line stably expressing the \u00b5OR and, determined ligand binding affinity (K<jats:sub>i<\/jats:sub>) and potency (EC<jats:sub>50<\/jats:sub>) of CAR, fentanyl, remifentanil, morphine or the endogenous ligand endomorphin-1. We found that \u00b5OR bind CAR with\u2009~\u200910-times higher affinity than fentanyl or remifentanil and with\u2009~\u200970-times higher affinity than morphine. Potency of CAR to inhibit cAMP was\u2009~\u200985-times higher compared to the fentanyl\u2019s and\u2009~\u2009620 higher compared to morphine. Thus, CAR\u2019s toxicity rather associates with receptor potency than affinity. When receptor occupancy at EC<jats:sub>50<\/jats:sub>-values was calculated, it appeared that CAR is\u2009~\u20098-times more efficient to inhibit cAMP in comparison to morphine, fentanyl or remifentanil. Hence, we postulate that CAR stabilizes \u00b5OR conformations that are ultra-efficient in inhibiting cAMP. The OR antagonists naloxone and nalmefene are used as antidotes against opioid intoxication. Both antagonists revealed 10 to 100-times higher IC<jats:sub>50<\/jats:sub>-values against CAR-mediated cAMP inhibition compared to the other opioids, indicating that \u00b5OR conformations stabilized by CAR are rather resistant towards clinically used antidotes. Of note, when the long acting OR antagonist naltrexone was tested, it exhibited a\u2009~\u200965-times higher potency to inhibit CAR but not fentanyl compared to naloxone. Our data highlight the unique nature of CAR\u2019s interactions with \u00b5OR and provide first pharmacodynamic indication that naltrexone might be a superior antidote.<\/jats:p>","DOI":"10.1007\/s00204-025-04048-6","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:05:21Z","timestamp":1746245121000},"page":"2903-2915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Carfentanil stabilizes \u00b5 opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone"],"prefix":"10.1007","volume":"99","author":[{"given":"Franziska","family":"Endt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Steinritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Amend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gudermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-2798","authenticated-orcid":false,"given":"Andreas","family":"Breit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"6108","key":"4048_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/bmj.1.6108.278","volume":"1","author":"AP Adams","year":"1978","unstructured":"Adams AP, Pybus DA (1978) Delayed respiratory depression after use of fentanyl during anaesthesia. Br Med J 1(6108):278\u2013279. https:\/\/doi.org\/10.1136\/bmj.1.6108.278","journal-title":"Br Med J"},{"issue":"4","key":"4048_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00000542-197604000-00003","volume":"44","author":"LD Becker","year":"1976","unstructured":"Becker LD, Paulson BA, Miller RD, Severinghaus JW, Eger EI 2nd (1976) Biphasic respiratory depression after fentanyldroperidol or fentanyl alone used to supplement nitrous oxide anesthesia. Anesthesiology 44(4):291\u2013296. https:\/\/doi.org\/10.1097\/00000542-197604000-00003","journal-title":"Anesthesiology"},{"issue":"2","key":"4048_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1074\/jbc.272.2.782","volume":"272","author":"AD Blake","year":"1997","unstructured":"Blake AD, Bot G, Freeman JC, Reisine T (1997) Differential opioid agonist regulation of the mouse mu opioid receptor. J Biol Chem 272(2):782\u2013790. https:\/\/doi.org\/10.1074\/jbc.272.2.782","journal-title":"J Biol Chem"},{"issue":"5","key":"4048_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/dta.3431","volume":"15","author":"SA Borden","year":"2023","unstructured":"Borden SA, Mercer SR, Saatchi A et al (2023) Carfentanil structural analogs found in street drugs by paper spray mass spectrometry and their characterization by high-resolution mass spectrometry. Drug Test Anal 15(5):484\u2013494. https:\/\/doi.org\/10.1002\/dta.3431","journal-title":"Drug Test Anal"},{"issue":"27","key":"4048_CR5","doi-asserted-by":"publisher","first-page":"28756","DOI":"10.1074\/jbc.M313310200","volume":"279","author":"A Breit","year":"2004","unstructured":"Breit A, Lagace M, Bouvier M (2004) Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 279(27):28756\u201328765. https:\/\/doi.org\/10.1074\/jbc.M313310200","journal-title":"J Biol Chem"},{"issue":"9","key":"4048_CR6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.cellsig.2008.05.004","volume":"20","author":"J Chu","year":"2008","unstructured":"Chu J, Zheng H, Loh HH, Law PY (2008) Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell Signal 20(9):1616\u20131624. https:\/\/doi.org\/10.1016\/j.cellsig.2008.05.004","journal-title":"Cell Signal"},{"issue":"1","key":"4048_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0024-3205(92)90199-y","volume":"50","author":"EM Costa","year":"1992","unstructured":"Costa EM, Hoffmann BB, Loew GH (1992) Opioid agonists binding and responses in SH-SY5Y cells. Life Sci 50(1):73\u201381. https:\/\/doi.org\/10.1016\/0024-3205(92)90199-y","journal-title":"Life Sci"},{"issue":"3","key":"4048_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.55460\/8N90-FU1K","volume":"17","author":"CE Cowles Jr","year":"2017","unstructured":"Cowles CE Jr, Mitchell J, Stepp JE, Bewley VZ (2017) Carfentanil: a new and often unrecognized threat. J Spec Oper Med 17(3):120\u2013122. https:\/\/doi.org\/10.55460\/8N90-FU1K","journal-title":"J Spec Oper Med"},{"issue":"5","key":"4048_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.15585\/mmwr.mm6905a2","volume":"69","author":"C Delcher","year":"2020","unstructured":"Delcher C, Wang Y, Vega RS et al (2020) Carfentanil Outbreak-Florida, 2016\u20132017. MMWR Morb Mortal Wkly Rep 69(5):125\u2013129. https:\/\/doi.org\/10.15585\/mmwr.mm6905a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"4048_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1476-5381.2011.01382.x","volume":"164","author":"C Doll","year":"2011","unstructured":"Doll C, Konietzko J, Poll F, Koch T, Hollt V, Schulz S (2011) Agonist-selective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol 164(2):298\u2013307. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01382.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4048_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/bja\/49.2.151","volume":"49","author":"GB Drummond","year":"1977","unstructured":"Drummond GB, Davie IT, Scott DB (1977) Naloxone: dose-dependent antagonism of respiratory depression by fentanyl in anaesthetized patients. Br J Anaesth 49(2):151\u2013154. https:\/\/doi.org\/10.1093\/bja\/49.2.151","journal-title":"Br J Anaesth"},{"issue":"7945","key":"4048_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","volume":"613","author":"A Faouzi","year":"2023","unstructured":"Faouzi A, Wang H, Zaidi SA et al (2023) Structure-based design of bitopic ligands for the micro-opioid receptor. Nature 613(7945):767\u2013774. https:\/\/doi.org\/10.1038\/s41586-022-05588-y","journal-title":"Nature"},{"key":"4048_CR13","doi-asserted-by":"publisher","first-page":"1359851","DOI":"10.3389\/fpsyt.2024.1359851","volume":"15","author":"MG Feasel","year":"2024","unstructured":"Feasel MG, Moran TS, Cheng BC, Averick S (2024) Are carfentanil and acrylfentanyl naloxone resistant? Front Psychiatry 15:1359851. https:\/\/doi.org\/10.3389\/fpsyt.2024.1359851","journal-title":"Front Psychiatry"},{"issue":"1","key":"4048_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s42003-021-02580-6","volume":"4","author":"S Fritzwanker","year":"2021","unstructured":"Fritzwanker S, Mouledous L, Mollereau C et al (2021) HA-MOP knockin mice express the canonical micro-opioid receptor but lack detectable splice variants. Commun Biol 4(1):1070. https:\/\/doi.org\/10.1038\/s42003-021-02580-6","journal-title":"Commun Biol"},{"issue":"4","key":"4048_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajem.2010.03.003","volume":"28","author":"AV George","year":"2010","unstructured":"George AV, Lu JJ, Pisano MV, Metz J, Erickson TB (2010) Carfentanil\u2013an ultra potent opioid. Am J Emerg Med 28(4):530\u2013532. https:\/\/doi.org\/10.1016\/j.ajem.2010.03.003","journal-title":"Am J Emerg Med"},{"issue":"36","key":"4048_CR16","doi-asserted-by":"publisher","first-page":"31731","DOI":"10.1074\/jbc.M111.248310","volume":"286","author":"CE Groer","year":"2011","unstructured":"Groer CE, Schmid CL, Jaeger AM, Bohn LM (2011) Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. J Biol Chem 286(36):31731\u201331741. https:\/\/doi.org\/10.1074\/jbc.M111.248310","journal-title":"J Biol Chem"},{"key":"4048_CR17","doi-asserted-by":"publisher","unstructured":"Gustafsson M, Silva V, Valeiro C, Joaquim J, van Hunsel F, Matos C (2024) Misuse, abuse and medication errors\u2019 adverse events associated with opioids\u2014a systematic review. Pharmaceuticals (Basel) 17(8). https:\/\/doi.org\/10.3390\/ph17081009","DOI":"10.3390\/ph17081009"},{"issue":"2","key":"4048_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7589\/0090-3558-19.2.140","volume":"19","author":"JC Haigh","year":"1983","unstructured":"Haigh JC, Lee LJ, Schweinsburg RE (1983) Immobilization of polar bears with carfentanil. J Wildl Dis 19(2):140\u2013144. https:\/\/doi.org\/10.7589\/0090-3558-19.2.140","journal-title":"J Wildl Dis"},{"issue":"1\u20133","key":"4048_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0304-3940(89)90688-5","volume":"100","author":"H Harada","year":"1989","unstructured":"Harada H, Ueda H, Wada Y, Katada T, Ui M, Satoh M (1989) Phosphorylation of mu-opioid receptors\u2014a putative mechanism of selective uncoupling of receptor\u2013Gi interaction, measured with low-Km GTPase and nucleotide-sensitive agonist binding. Neurosci Lett 100(1\u20133):221\u2013226. https:\/\/doi.org\/10.1016\/0304-3940(89)90688-5","journal-title":"Neurosci Lett"},{"issue":"2","key":"4048_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0006-291x(86)91152-6","volume":"137","author":"SM Kazmi","year":"1986","unstructured":"Kazmi SM, Mishra RK (1986) Opioid receptors in human neuroblastoma SH-SY5Y cells: evidence for distinct morphine (mu) and enkephalin (delta) binding sites. Biochem Biophys Res Commun 137(2):813\u2013820. https:\/\/doi.org\/10.1016\/0006-291x(86)91152-6","journal-title":"Biochem Biophys Res Commun"},{"key":"4048_CR21","doi-asserted-by":"publisher","unstructured":"Kelly E, Bailey CP, Henderson G (2008) Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 153 Suppl 1(Suppl 1):S379\u201388 https:\/\/doi.org\/10.1038\/sj.bjp.0707604","DOI":"10.1038\/sj.bjp.0707604"},{"key":"4048_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-pharmtox-052120-091058","volume":"63","author":"E Kelly","year":"2023","unstructured":"Kelly E, Conibear A, Henderson G (2023) Biased Agonism: lessons from studies of opioid receptor agonists. Annu Rev Pharmacol Toxicol 63:491\u2013515. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052120-091058","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4048_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2024.102507","volume":"71","author":"H Khatoon","year":"2024","unstructured":"Khatoon H, Faudzi SMM (2024) Balancing acts: the dual faces of fentanyl in medicine and public health. Leg Med (Tokyo) 71:102507. https:\/\/doi.org\/10.1016\/j.legalmed.2024.102507","journal-title":"Leg Med (Tokyo)"},{"key":"4048_CR24","doi-asserted-by":"publisher","unstructured":"Kirchmayer U, Davoli M, Verster A (2000) Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev(2):CD001333. https:\/\/doi.org\/10.1002\/14651858.CD001333","DOI":"10.1002\/14651858.CD001333"},{"issue":"4","key":"4048_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbamem.2006.10.021","volume":"1768","author":"BK Kobilka","year":"2007","unstructured":"Kobilka BK (2007) G protein coupled receptor structure and activation. Biochim Biophys Acta 1768(4):794\u2013807. https:\/\/doi.org\/10.1016\/j.bbamem.2006.10.021","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"4048_CR26","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1111\/bph.15811","volume":"179","author":"P Kolb","year":"2022","unstructured":"Kolb P, Kenakin T, Alexander SPH et al (2022) Community guidelines for GPCR ligand bias: IUPHAR review 32. Br J Pharmacol 179(14):3651\u20133674. https:\/\/doi.org\/10.1111\/bph.15811","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4048_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1124\/jpet.118.256115","volume":"371","author":"P Krieter","year":"2019","unstructured":"Krieter P, Gyaw S, Crystal R, Skolnick P (2019) Fighting fire with fire: development of intranasal nalmefene to treat synthetic opioid overdose. J Pharmacol Exp Ther 371(2):409\u2013415. https:\/\/doi.org\/10.1124\/jpet.118.256115","journal-title":"J Pharmacol Exp Ther"},{"key":"4048_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.toxlet.2020.02.008","volume":"325","author":"JL Langston","year":"2020","unstructured":"Langston JL, Moffett MC, Makar JR, Burgan BM, Myers TM (2020) Carfentanil toxicity in the African green monkey: therapeutic efficacy of naloxone. Toxicol Lett 325:34\u201342. https:\/\/doi.org\/10.1016\/j.toxlet.2020.02.008","journal-title":"Toxicol Lett"},{"issue":"4","key":"4048_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12630-019-01294-y","volume":"66","author":"JLS Leen","year":"2019","unstructured":"Leen JLS, Juurlink DN (2019) Carfentanil: a narrative review of its pharmacology and public health concerns. Can J Anaesth 66(4):414\u2013421. https:\/\/doi.org\/10.1007\/s12630-019-01294-y","journal-title":"Can J Anaesth"},{"issue":"6","key":"4048_CR30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3892\/mmr.2012.1073","volume":"6","author":"Z Li","year":"2012","unstructured":"Li Z, Pei Q, Cao L, Xu L, Zhang B, Liu S (2012) Propofol increases micro-opioid receptor expression in SH-SY5Y human neuroblastoma cells. Mol Med Rep 6(6):1333\u20131336. https:\/\/doi.org\/10.3892\/mmr.2012.1073","journal-title":"Mol Med Rep"},{"key":"4048_CR31","doi-asserted-by":"publisher","unstructured":"Lipinski PFJ, Kosson P, Matalinska J et al (2019) Fentanyl family at the mu-opioid receptor: uniform assessment of binding and computational analysis. Molecules 24(4). https:\/\/doi.org\/10.3390\/molecules24040740","DOI":"10.3390\/molecules24040740"},{"issue":"2","key":"4048_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jemermed.2009.09.026","volume":"40","author":"EB Lust","year":"2011","unstructured":"Lust EB, Barthold C, Malesker MA, Wichman TO (2011) Human health hazards of veterinary medications: information for emergency departments. J Emerg Med 40(2):198\u2013207. https:\/\/doi.org\/10.1016\/j.jemermed.2009.09.026","journal-title":"J Emerg Med"},{"issue":"45","key":"4048_CR33","doi-asserted-by":"publisher","first-page":"34515","DOI":"10.1074\/jbc.M604278200","volume":"281","author":"TA Macey","year":"2006","unstructured":"Macey TA, Lowe JD, Chavkin C (2006) Mu opioid receptor activation of ERK1\/2 is GRK3 and arrestin dependent in striatal neurons. J Biol Chem 281(45):34515\u201334524. https:\/\/doi.org\/10.1074\/jbc.M604278200","journal-title":"J Biol Chem"},{"issue":"5630","key":"4048_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1126\/science.1084674","volume":"301","author":"T Manzke","year":"2003","unstructured":"Manzke T, Guenther U, Ponimaskin EG et al (2003) 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 301(5630):226\u2013229. https:\/\/doi.org\/10.1126\/science.1084674","journal-title":"Science"},{"key":"4048_CR35","doi-asserted-by":"publisher","unstructured":"Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A (2006) Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev(1):CD001333. https:\/\/doi.org\/10.1002\/14651858.CD001333.pub2","DOI":"10.1002\/14651858.CD001333.pub2"},{"issue":"2","key":"4048_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1471-4159.2009.06156.x","volume":"110","author":"M Miyatake","year":"2009","unstructured":"Miyatake M, Rubinstein TJ, McLennan GP, Belcheva MM, Coscia CJ (2009) Inhibition of EGF-induced ERK\/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways. J Neurochem 110(2):662\u2013674. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06156.x","journal-title":"J Neurochem"},{"issue":"1","key":"4048_CR37","doi-asserted-by":"publisher","first-page":"17395","DOI":"10.1038\/s41598-020-73674-0","volume":"10","author":"TC Moller","year":"2020","unstructured":"Moller TC, Pedersen MF, van Senten JR et al (2020) Dissecting the roles of GRK2 and GRK3 in mu-opioid receptor internalization and beta-arrestin2 recruitment using CRISPR\/Cas9-edited HEK293 cells. Sci Rep 10(1):17395. https:\/\/doi.org\/10.1038\/s41598-020-73674-0","journal-title":"Sci Rep"},{"issue":"3","key":"4048_CR38","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/ALN.0000000000000984","volume":"124","author":"G Montandon","year":"2016","unstructured":"Montandon G, Ren J, Victoria NC et al (2016) G-protein-gated inwardly rectifying potassium channels modulate respiratory depression by opioids. Anesthesiology 124(3):641\u2013650. https:\/\/doi.org\/10.1097\/ALN.0000000000000984","journal-title":"Anesthesiology"},{"issue":"6","key":"4048_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s11920-001-0042-x","volume":"3","author":"G O'Leary","year":"2001","unstructured":"O\u2019Leary G, Borrow J, Weiss RD (2001) Opioid antagonists in the treatment of alcohol dependence. Curr Psychiatry Rep 3(6):484\u2013488. https:\/\/doi.org\/10.1007\/s11920-001-0042-x","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"4048_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049463712438493","volume":"6","author":"H Pathan","year":"2012","unstructured":"Pathan H, Williams J (2012) Basic opioid pharmacology: an update. Br J Pain 6(1):11\u201316. https:\/\/doi.org\/10.1177\/2049463712438493","journal-title":"Br J Pain"},{"issue":"6","key":"4048_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","volume":"100","author":"KT Pattinson","year":"2008","unstructured":"Pattinson KT (2008) Opioids and the control of respiration. Br J Anaesth 100(6):747\u2013758. https:\/\/doi.org\/10.1093\/bja\/aen094","journal-title":"Br J Anaesth"},{"issue":"2","key":"4048_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0026-895X(25)10234-4","volume":"48","author":"G Pei","year":"1995","unstructured":"Pei G, Kieffer BL, Lefkowitz RJ, Freedman NJ (1995) Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol Pharmacol 48(2):173\u2013177","journal-title":"Mol Pharmacol"},{"key":"4048_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109906","volume":"80","author":"G Pineyro","year":"2021","unstructured":"Pineyro G, Nagi K (2021) Signaling diversity of mu- and delta- opioid receptor ligands: re-evaluating the benefits of beta-arrestin\/G protein signaling bias. Cell Signal 80:109906. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109906","journal-title":"Cell Signal"},{"issue":"18","key":"4048_CR44","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1111\/bph.16084","volume":"180","author":"N Ramos-Gonzalez","year":"2023","unstructured":"Ramos-Gonzalez N, Groom S, Sutcliffe KJ et al (2023) Carfentanil is a beta-arrestin-biased agonist at the mu opioid receptor. Br J Pharmacol 180(18):2341\u20132360. https:\/\/doi.org\/10.1111\/bph.16084","journal-title":"Br J Pharmacol"},{"issue":"9","key":"4048_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jat\/bks078","volume":"36","author":"JR Riches","year":"2012","unstructured":"Riches JR, Read RW, Black RM, Cooper NJ, Timperley CM (2012) Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use. J Anal Toxicol 36(9):647\u2013656. https:\/\/doi.org\/10.1093\/jat\/bks078","journal-title":"J Anal Toxicol"},{"issue":"1","key":"4048_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1124\/jpet.112.192757","volume":"342","author":"K Rothe","year":"2012","unstructured":"Rothe K, Solinski HJ, Boekhoff I, Gudermann T, Breit A (2012) Morphine activates the E twenty six-like transcription factor-1\/serum response factor pathway via extracellular signal-regulated kinases 1\/2 in F11 cells derived from dorsal root ganglia neurons. J Pharmacol Exp Ther 342(1):41\u201352. https:\/\/doi.org\/10.1124\/jpet.112.192757","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"4048_CR47","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1096\/fj.06-7793com","volume":"21","author":"R Rozenfeld","year":"2007","unstructured":"Rozenfeld R, Devi LA (2007) Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J 21(10):2455\u20132465. https:\/\/doi.org\/10.1096\/fj.06-7793com","journal-title":"FASEB J"},{"issue":"4","key":"4048_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1474-8673.1982.tb00520.x","volume":"2","author":"RR Ruffolo Jr","year":"1982","unstructured":"Ruffolo RR Jr (1982) Review important concepts of receptor theory. J Auton Pharmacol 2(4):277\u2013295. https:\/\/doi.org\/10.1111\/j.1474-8673.1982.tb00520.x","journal-title":"J Auton Pharmacol"},{"issue":"16","key":"4048_CR49","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/sj.emboj.7600334","volume":"23","author":"S Schulz","year":"2004","unstructured":"Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, Hollt V (2004) Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 23(16):3282\u20133289. https:\/\/doi.org\/10.1038\/sj.emboj.7600334","journal-title":"EMBO J"},{"key":"4048_CR50","doi-asserted-by":"publisher","unstructured":"Soldner CA, Horn AHC, Sticht H (2019) A metadynamics-based protocol for the determination of GPCR-ligand binding modes. Int J Mol Sci 20(8). https:\/\/doi.org\/10.3390\/ijms20081970","DOI":"10.3390\/ijms20081970"},{"issue":"2","key":"4048_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-2999(89)90582-7","volume":"167","author":"M Titeler","year":"1989","unstructured":"Titeler M, Lyon RA, Kuhar MJ et al (1989) Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. Eur J Pharmacol 167(2):221\u2013228. https:\/\/doi.org\/10.1016\/0014-2999(89)90582-7","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"4048_CR52","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1074\/jbc.M106457200","volume":"277","author":"A Tohgo","year":"2002","unstructured":"Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277(11):9429\u20139436. https:\/\/doi.org\/10.1074\/jbc.M106457200","journal-title":"J Biol Chem"},{"key":"4048_CR53","doi-asserted-by":"publisher","unstructured":"Van Bever WF, Niemegeers CJ, Janssen PA (1974) Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide and N-(3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. J Med Chem 17(10):1047\u20131051. https:\/\/doi.org\/10.1021\/jm00256a003","DOI":"10.1021\/jm00256a003"},{"key":"4048_CR54","doi-asserted-by":"publisher","unstructured":"Wang DS, Sternbach G, Varon J (1998) Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine. J Emerg Med 16(3):471\u2013475. https:\/\/doi.org\/10.1016\/s0736-4679(98)00019-5","DOI":"10.1016\/s0736-4679(98)00019-5"},{"issue":"1","key":"4048_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G et al (2013) Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65(1):223\u2013254. https:\/\/doi.org\/10.1124\/pr.112.005942","journal-title":"Pharmacol Rev"},{"issue":"1","key":"4048_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12024-020-00321-5","volume":"17","author":"F Yung","year":"2021","unstructured":"Yung F, Herath J (2021) An investigation of demographic and drug-use patterns in fentanyl and carfentanil deaths in Ontario. Forensic Sci Med Pathol 17(1):64\u201371. https:\/\/doi.org\/10.1007\/s12024-020-00321-5","journal-title":"Forensic Sci Med Pathol"},{"key":"4048_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110715","volume":"320","author":"JB Zawilska","year":"2021","unstructured":"Zawilska JB, Kuczynska K, Kosmal W, Markiewicz K, Adamowicz P (2021) Carfentanil\u2014from an animal anesthetic to a deadly illicit drug. Forensic Sci Int 320:110715. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110715","journal-title":"Forensic Sci Int"},{"issue":"19","key":"4048_CR58","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1074\/jbc.271.19.11449","volume":"271","author":"L Zhang","year":"1996","unstructured":"Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB (1996) Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271(19):11449\u201311454. https:\/\/doi.org\/10.1074\/jbc.271.19.11449","journal-title":"J Biol Chem"},{"issue":"1","key":"4048_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S (2024) G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther 9(1):88. https:\/\/doi.org\/10.1038\/s41392-024-01803-6","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4048_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1124\/mol.107.039842","volume":"73","author":"H Zheng","year":"2008","unstructured":"Zheng H, Loh HH, Law PY (2008) Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation. Mol Pharmacol 73(1):178\u2013190. https:\/\/doi.org\/10.1124\/mol.107.039842","journal-title":"Mol Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04048-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T13:52:19Z","timestamp":1750859539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04048-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4048"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04048-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}